Autolus Therapeutics plc (6A3A) — Financial Flexibility Index
Autolus Therapeutics plc (6A3A) has a Financial Flexibility Index of -0.16x as of December 2025. Free cash flow of €-67.32 Million (operating CF €-67.32 Million minus capex €0.00) represents 0% of total liabilities (€410.94 Million). Also explore Autolus Therapeutics plc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Autolus Therapeutics plc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Autolus Therapeutics plc across 9 annual periods. Check 6A3A strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Autolus Therapeutics plc (2017–2025)
Year-by-year free cash flow to debt coverage for Autolus Therapeutics plc. For the full company profile including market capitalisation, see Autolus Therapeutics plc (6A3A) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | €-256.44 Million | €-283.57 Million | €410.94 Million | ▼ -29.4% |
| 2024 | -0.48x | €-171.45 Million | €-206.27 Million | €355.40 Million | ▲ +5.4% |
| 2023 | -0.51x | €-134.60 Million | €-145.59 Million | €263.91 Million | ▲ +3.7% |
| 2022 | -0.53x | €-101.47 Million | €-112.31 Million | €191.60 Million | ▲ +55.2% |
| 2021 | -1.18x | €-109.00 Million | €-117.86 Million | €92.24 Million | ▲ +3.5% |
| 2020 | -1.22x | €-103.08 Million | €-117.76 Million | €84.20 Million | ▲ +28.3% |
| 2019 | -1.71x | €-83.14 Million | €-101.48 Million | €48.69 Million | ▼ -1.8% |
| 2018 | -1.68x | €-29.75 Million | €-42.52 Million | €17.74 Million | ▲ +24.6% |
| 2017 | -2.22x | €-13.48 Million | €-16.36 Million | €6.06 Million | — |